|
Market Closed -
OTC Markets
22:12:15 28/07/2025 +03
|
5-day change | 1st Jan Change | ||
| 30.92 USD | +24.45% |
|
-.--% | - |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.18x | 4.79x | 2.55x | 6.41x | 22.23x | 26.92x | 0.92% | 46.37B | |
| 15.96x | 1.78x | 7.64x | 1.97x | 8.77x | 11.13x | 1.69% | 37.26B | |
| 28.87x | 3.97x | -1.72x | 4.1x | 17.01x | 23.82x | 0.56% | 12.53B | |
| 27.25x | 3.01x | 3.88x | 3.31x | 17.13x | 21.98x | 0.93% | 11.8B | |
| 18.58x | 3.38x | 3.15x | 3.37x | 11.75x | 13.98x | 3.79% | 8.97B | |
| 15.51x | 1.29x | 2.58x | 2.06x | 6.85x | 9.72x | 3.21% | 7.29B | |
| 9.18x | 1.51x | 1.32x | 2.12x | 5.48x | 6.66x | 4.84% | 7.09B | |
| 28.95x | 5.31x | 0.41x | 3.78x | 17.59x | 21.21x | 0.16% | 7.01B | |
| 35.39x | 8.18x | 1.9x | 6.9x | 25.23x | 27.85x | 0.98% | 4.62B | |
| 15.95x | 0.78x | -0.03x | 2.2x | 9.4x | 11.89x | 1.69% | 4.27B | |
| 13.91x | 2.31x | 0.51x | 2.29x | 10.31x | 10.14x | 3.76% | 3.66B | |
| 15.87x | 2.81x | -9.45x | 3.21x | 12.08x | 14.41x | 3.07% | 2.77B | |
| 18.76x | 4.76x | 4.22x | 5.34x | 16.01x | 17.52x | 3.22% | 2.42B | |
| 13.02x | - | -0.85x | 9.06x | 8.89x | 9.16x | - | 2.29B | |
| 29.66x | 4.88x | 2.17x | - | - | - | - | 2.25B | |
| Average | 21.40x | 3.48x | 1.22x | 4.01x | 13.48x | 16.17x | 2.22% | 10.71B | |
| Weighted average by Cap. | 24.15x | 3.42x | 3.01x | 4.04x | 15.01x | 18.52x | 1.66% |
- Stock Market
- Stocks
- RICHTER Stock
- GEDSF Stock
- Sector Gedeon Richter
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
